View in EDS

Validation of the modified Glasgow Prognostic Score (mGPS) in recurrent ovarian cancer (ROC) – Analysis of patients enrolled in the GCIG Symptom Benefit Study (SBS).

Saved in:
Bibliographic Details
Title: Validation of the modified Glasgow Prognostic Score (mGPS) in recurrent ovarian cancer (ROC) – Analysis of patients enrolled in the GCIG Symptom Benefit Study (SBS).
Authors: Roncolato, Felicia T.1,2,3 felicia.roncolato@ctc.usyd.edu.au, Berton-Rigaud, Dominique4, O'Connell, Rachel1, Lanceley, Anne5, Sehouli, Jalid6, Buizen, Luke1, Okamoto, Aikou7, Aotani, Eriko8, Lorusso, Domenica9, Donnellan, Paul10,11, Oza, Amit12, Avall-Lundqvist, Elisabeth13, Berek, Jonathan14, Hilpert, Felix15, Ledermann, Jonathan A.16, Kaminsky, Marie Christine17, Stockler, Martin R.1, King, Madeleine T.18, Friedlander, Michael3,19
Source: Gynecologic Oncology. Jan2018, Vol. 148 Issue 1, p36-41. 6p.
Database: Academic Search Ultimate
Description
ISSN:00908258
DOI:10.1016/j.ygyno.2017.10.019